New Insights into Pain Issues in Long COVID

Medical News: A new study by researchers from Mount Sinai's Cohen Center for Recovery from Complex Chronic Illness-USA, NYU Grossman School of Medicine-USA, and the Polybio Research Foundation-USA sheds light on the nature of long COVID pain, highlighting differences between neuropathic and non-neuropathic pain and their impact on quality of life and cognitive functioning. The research findings provide a deeper understanding of the mechanisms underlying pain in long COVID patients. This Medical News report explains the key findings of this important study.


New Insights into Pain Issues in Long COVID

Long COVID Pain: What We Know
Long COVID, also known as post-acute COVID syndrome, continues to affect millions of people worldwide. Symptoms vary widely, with over 200 different issues reported, but pain is among the most debilitating problems for many. In particular, patients often report new-onset pain months after their initial COVID-19 infection. Understanding what causes this pain and how it differs among individuals is crucial for developing effective treatments.
 
Researchers sought to investigate whether this pain could be divided into subtypes - specifically neuropathic pain (caused by nerve damage) and non-neuropathic pain. For this study, 153 long COVID patients were assessed at a clinic based in Mount Sinai, and their pain symptoms were thoroughly analyzed.
 
What the Study Found
Out of the 153 individuals in the study, 20.3% were found to have neuropathic pain. Neuropathic pain is often more severe and harder to manage than other types of pain. It can result from nerve damage or dysfunction and often causes tingling, burning, or shooting pain sensations.
 
The remaining participants (around 80%) experienced non-neuropathic pain, which was generally musculoskeletal, meaning it affected the muscles, bones, or joints. Though this type of pain may be less severe than neuropathic pain, it still significantly affects daily life and overall well-being.
 
What makes these findings even more significant is the way these two types of pain correlate with other symptoms. Those with neuropathic pain were more likely to experience cognitive dysfunction, commonly referred to as "brain fog." This includes difficulty concentrating, remembering, and thinking clearly.
 
Pain’s Impact on Quality of Life
Both neuropathic and non-neuropathic pain were linked to a decline in quality of life. However, patients with neuropathic pain reported a much lower quality of life compared to those with non-neuropathic pain. They also showed a significant decrease in cognitive functioning, which was measured through the EuroQoL Visual Analog Scale and NeuroQoL (Quality of Life in Neurological Disorders) assessments.
 
This research shows that pain and cognitive dysfunction are closely linked in long COVID patients. As the study explains, “The presence of cognitive dysfunction is substantially higher in patients with neuropathic pain than in those with non-neu ropathic pain.” This adds to the growing body of evidence that chronic pain, particularly neuropathic pain, can affect the brain's ability to function normally.
 
How Does Long COVID Cause Neuropathic Pain?
One of the most important questions this study addresses is how long COVID might cause neuropathic pain. The answer seems to lie in the body's immune response to the virus. Neuropathic pain in long COVID is thought to be linked to inflammation caused by an overactive immune response. Specifically, the body’s release of cytokines (proteins that control immune system activity) can lead to nerve damage.
 
In some cases, the SARS-CoV-2 virus may also directly infect nerve cells, leading to the type of nerve damage seen in neuropathic pain. This is similar to how viruses like herpes or chickenpox can cause nerve pain (shingles). In this case, the virus might persist in the body’s nerve cells even after the initial infection has cleared.
 
Differences in Symptoms Between Pain Groups
Interestingly, while both neuropathic and non-neuropathic pain groups reported many of the same symptoms, a few key differences emerged. Those with neuropathic pain were more likely to suffer from headaches, confusion, and generalized muscle weakness. Meanwhile, individuals with non-neuropathic pain reported mood swings, irritability, and shortness of breath more frequently.

Understanding these symptom patterns is important for clinicians, as it can help them better diagnose and manage pain in long COVID patients. For example, someone experiencing new-onset headaches and muscle weakness after COVID might be more likely to develop neuropathic pain.
 
Managing Pain in Long COVID
Given the complexity of long COVID pain, what can be done to help patients?
The study authors emphasize the need for personalized treatment approaches. Neuropathic pain often requires different treatment strategies than musculoskeletal pain. While physical therapy and medications like acetyl-carnitine have been shown to help musculoskeletal pain, neuropathic pain may require medications that target nerve damage, such as gabapentin or pregabalin.
 
Additionally, managing inflammation might be key to preventing or reducing neuropathic pain in long COVID patients. Some researchers believe that therapies aimed at controlling the body’s immune response could help reduce the incidence of nerve damage and associated pain.
 
What Does This Mean for Long COVID Patients?
For the millions of people around the world suffering from long COVID, these findings bring hope for better diagnosis and treatment. By distinguishing between different types of pain, doctors can more effectively target treatments and improve the quality of life for patients.
 
Cognitive symptoms, such as brain fog, are also important to address in patients with neuropathic pain, as these issues can significantly affect a person’s ability to function in daily life. Healthcare providers need to be aware of the potential links between pain and cognitive decline to provide comprehensive care.
 
Future Research
This study opens the door to more in-depth research on the mechanisms of pain in long COVID. While we now know that inflammation and nerve damage likely play a role, more work is needed to fully understand the processes that cause neuropathic pain.
 
There is also a need for larger studies to confirm these findings and to explore whether factors like age, gender, and vaccination status affect the likelihood of developing different types of pain after COVID.
 
Conclusion
In conclusion, this research offers crucial insights into the nature of long COVID-related pain. The study not only highlights the prevalence of neuropathic and non-neuropathic pain but also underscores their impact on cognitive functioning and quality of life. For those suffering from long COVID, understanding these distinctions could lead to better treatment outcomes and improved quality of life.
 
Healthcare providers must pay close attention to the specific type of pain each long COVID patient experiences, as this will guide treatment decisions and improve long-term care. Furthermore, the links between pain, cognitive dysfunction, and inflammatory processes require further exploration to develop more targeted therapies for long COVID patients.
 
The study findings were published in the peer-reviewed journal: Frontiers in Rehabilitation Science.
https://www.frontiersin.org/journals/rehabilitation-sciences/articles/10.3389/fresc.2024.1448816/full
 
For the latest COVID-19 News, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/new-insights-reveal-how-covid-19-causes-persistent-pain-and-inflammation
 
https://www.thailandmedical.news/news/covid-19-s-unexpected-impact-rising-orofacial-pain-among-infected-individuals
 
https://www.thailandmedical.news/news/unraveling-neuropathic-pain-the-role-of-inflammation-iron-and-receptors
 
https://www.thailandmedical.news/news/mechanisms-of-muscle-pain-in-long-covid
 
https://www.thailandmedical.news/news/thailand-medical-researchers-develop-new-transdermal-delivery-system-for-painkiller-diclofenac-sodium
 
https://www.thailandmedical.news/news/does-covid-19-affects-kidney-and-liver-health-when-taking-common-painkiller